Antimicrobial resistance and β-lactamase production of clinical isolates of Prevotella and Porphyromonas species

Chemotherapy

Volumn 51, Issue 1, 2005, Pages 9-14

  Bahar, Hrisi ^a   Torun, Müzeyyen Mamal ^a   Demirci, Mehmet ^a   Kocazeybek, Bekir ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antimicrobial resistance; E test; Porphyromonas species; Prevotella species

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; NITROCEFIN; PENICILLIN G; SULTAMICILLIN; BETA LACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; ENZYME SYNTHESIS; PORPHYROMONAS; PORPHYROMONAS ASACCHAROLYTICA; PORPHYROMONAS GINGIVALIS; PREVOTELLA; PREVOTELLA BIVIA; PREVOTELLA DENTICOLA; PREVOTELLA INTERMEDIA; PREVOTELLA LOESCHEII; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL; SPECIES DIFFERENCE; STRAIN IDENTIFICATION; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PORPHYROMONAS; PREVOTELLA; PROSPECTIVE STUDIES;

EID: 21344437706     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084017     Document Type: Article

References (34)

1. Evaldson G, Heimdahl A, Kager L, Nord CE: The normal human anaerobic microflora. Scand J Infect Dis Suppl 1982;35:9-15.
2. Brook I: Prevotella and Porphyromonas infections in children. J Med Microbiol 1995;42:340-347.
3. Brook I: Joint and bone infections due to anaerobic bacteria in children. Pediatr Rehabil 2002;5:11-19.
4. Fosse T, Madinier I, Hitzig C, Charbit Y: Prevalence of beta-lactamase-producing strains among 149 anaerobic gram-negative rods isolated from periodontal pockets. Oral Microbiol Immunol 1999;14:352-357.
5. Civen R, Jousimies-Somer H, Marina M, Borenstein L, Shah H, Finegold SM: A retrospective review of cases of anaerobic empyema and update of bacteriology. Clin Infect Dis 1995;20(suppl 2):S224-S229.
6. Aldridge KE: The occurrence, virulence and antimicrobial resistance of anaerobes in polymicrobial infections. Am J Surg 1995;169:2-7.
7. Brook I: Pathogenesis and management of polymicrobial infections due to aerobic and anaerobic bacteria. Med Res Rev 1995;15:73-82.
8. Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE: Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas and Peptostreptococcus species. Antimicrob Agents Chemother 2001;45:1238-1243.
9. Wexler MH, Molitoris E, Molitoris D, Finegold SM: In vitro activity of HMR 3004 (RU 64004) against 502 strains of anaerobic bacteria. Anaerobe 1999;5:65-68.
10. Rasmussen BA, Bush K, Tally FP: Antimicrobial resistance in anaerobes. Clin Infect Dis 1997;24(suppl 1):S110-S120.
11. Mikamo H, Hua YX, Hayasaki Y, Satoh M, Kai J, Tamaya T: In vitro bactericidal activity and morphologic change in Bacteroides fragilis and Prevotella bivia with azithromycin. Curr Ther Res Clin 2000;61:549-552.
12. Loivukene K, Naaber P: Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe 2003;9:57-61.
13. Cullmann W, Frei R, Krech T: Antibacterial activity of oral antibiotics against anaerobic bacteria. Chemotherapy 1993;39:169-174.
14. Summanen P, Baron EJ, Citron DM, Strong CA, Wexler HM, Finegold SM: Wadsworth Anaerobic Bacteriology Manual, ed 5. Belmont, Star Publishing, 1993.
15. Citron DM: Rapid identification of anaerobes in the clinical laboratory. Anaerobe 1999;5:109-113.
16. Rosenblatt JE, Gustafson DR: Evaluation of the E test for the susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis 1995;22:279-284.
17. Citron DM, Ostovari MI, Karlsson A, Goldstein EJ: Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 1991;29:2197-2203.
18. Letournel-Glomaud C, Houssaye S, Milhaiha L, Ghnassia JC: E-test antibiotics susceptibility of strict anaerobic bacteria. Anaerobe 2003;9:281-284.
19. National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria, ed 6. Approved standard. NCCLS document M11-A6. Wayne, 2004.
20. Riesbeck K: Paronychia due to Prevotella bivia that resulted in amputation: Fast and correct bacteriological diagnosis is crucial. J Clin Microbiol 2003;41:4901-4903.
21. Panigrahi D, Rotimi VO, Dhar R, Chung TD, Dhar PM, Ghali A, Saad A, Sanyal SC, Varghese TL: Anaerobic bacterial flora of intraabdominal infections and their antimicrobial susceptibility pattern in Kuwait. Anaerobe 2001;7:291-295.
22. Handal T, Caugant DA, Olsen I: Antibiotic resistance in bacteria isolated from subgingival plaque in a Norwegian population with refractory marginal periodontitis. Antimicrob Agents Chemother 2003;47:1443-1446.
23. Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, Nakamura S: Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2001;16:10-15.
24. Lewis RP, Sutter VL, Finegold SM: Bone infection involving anaerobic bacteria. Medicine (Baltimore) 1978;4:279-305.
25. Brook I: Aerobic and anaerobic bacteriology of intracranial abscesses. Pediatr Neurol 1992;8:210-214.
26. Mikamo H, Sato Y, Hayasaki Y, Kawazoe K, Izumi K, Satoh M, Kai J, Tamaya T: In vitro bactericidal activities of antimicrobial agents and morphologic changes on Prevotella bivia. Chemotherapy 1999;45:342-348.
27. Herrera D, Van Winkelhoff AJ, Dellemijn-Kippuw N, Winkel EG, Sanz M: Beta-lactamase producing bacteria in the subgingival microflora of adult patients with periodontitis. A comparison between Spain and the Netherlands. J Clin Periodontol 2000;27:520-525.
28. Mory F, Lozniewski A, Bland S, Sedallian A, Grollier G, Girard-Pipau F, Paris MF, Dubreuil L: Survey of anaerobic susceptibility patterns: A French multicentre study. Int J Antimicrob Agents 1998;10:229-236.
29. Jacobs MP, Spangler SK, Applebaum PC: Beta-lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. Eur J Clin Microbiol Infect Dis 1992;11:1081-1093.
30. Hecht DV: Resistance trends in anaerobic bacteria. Clin Microbiol Newslett 2000;22:41-44.
31. Behra-Miellet J, Calvet L, Mory F, Muller C, Chomarat M, Bezian MC, Bland S, Juvenin ME, Fosse T, Goldstein F, Jaulhac B, Dubreuil L: Antibiotic resistance among anaerobic gram-negative bacilli: Lessons from a French multicentric survey. Anaerobe 2003;9:105-111.
32. Mattö J, Asikainen S, Vaisanen ML, Troil-Linden BV, Könönen E, Saarela M, Salminen K, Finegold SM, Jousimies-Somer H: Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents. Antimicrob Agents Chemother 1999;43:2383-2388.
33. Andrés MT, Chung WO, Roberts MC, Fierro JF: Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother 1998;42:3022-3023.
34. Kleinkauf N, Ackermann G, Schaumann R, Rodloff AC: Comparative in vitro activities of gemifloxacin, other quinolones and nonquinolone antimicrobials against obligately anaerobic bacteria. Antimicrob Agents Chemother 2001;45:1896-1899.